GlaxoSmithKline Valuation Analysis

Updated: about 1 year ago

Uncover the valuation of GlaxoSmithKline. Assess the company's price-to-earnings ratio (P/E), price-to-book ratio (P/B), and more for informed investment decisions.

GlaxoSmithKline PLC ADR Details

GlaxoSmithKline PLC ADR Valuation

When assessing the value of GlaxoSmithKline PLC ADR stock, it's crucial to consider a range of essential metrics that shed light on its true worth.

Key Valuation Metrics

Explore the following metrics and their implications:

  • Price-to-Earnings Ratio (P/E ratio): A higher P/E ratio can indicate higher growth expectations, while a lower ratio may signal undervaluation.
  • Price/Earnings to Growth (PEG) Ratio: The PEG ratio combines P/E ratio and earnings growth, offering insight into the stock's valuation adjusted for growth prospects.
  • Price-to-Book Ratio (P/B ratio): This ratio compares the stock's price to its book value per share, revealing its relative value.
  • Price-to-Sales Ratio: Compares market price to revenue, helping to gauge the stock's revenue potential.

GlaxoSmithKline Stock Metrics

Metric Value
Price-to-Earnings Ratio (P/E ratio) 12.01
Price/Earnings to Growth (PEG) Ratio: 1.125
Price-to-Book Ratio (P/B ratio): 6.55
Price-to-Sales Ratio: 1.864

Considering these valuation metrics can help you form a comprehensive view of GlaxoSmithKline PLC ADR stock's potential. Remember, every metric contributes a unique perspective to the evaluation process.

Top